← Back to Patent Explorer
US4682594A Expired / Lapsed US ⏱️ 0.0 years remaining

Probe-and-fire lasers

Assignee: MCM LABORATORIES Inc 1945 CHARLESTON ROAD STE 103 MOUNTAIN VIEW CA 94043 A CORP OF CA
•
Filing: 1985-10-18
•
Granted: 1987-07-28
•
Expires: 2005-10-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Method and apparatus of irradiating a treatment area within a body includes introducing elongated flexible radiation transfer conduit (fiberoptic arrays) into the body cavity with the distal end thereof operatively opposite the treatment area. At the other end of the conduit there is photoelectrically sensed a particular optical characteristic of the treatment area (such as fluorescence) and as long as the particular optical characteristic is sensed there is periodically transmitted laser pulses via the conduit to the treatment site.

Inventors

  • 👤 Walter Y. W. Mok

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 01:33
CPC Classifications
A; A61; A61B; A61B18/00; A61B18/18; A61B18/20; A61B18/22; A61B18/24; A61B18/245; A61B17/00; A61B2017/00017; A61B2017/00137; A61B2017/00154; A61B2018/00636

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 127 words
The method of destroying atheromatous plaque within an artery of a patient comprising the steps of initially administering to the patient a non-toxic atheroma-enhancing reagent which causes the plaque to have a characteristic optical property when illuminated with a given radiation, introducing a catheter system including fiberoptic cable means into the artery such that the distal end thereof is operatively opposite the plaque site, introducing into the proximal end of said fiberoptic cable means said given radiation, photoelectrically sensing at said proximal end said characteristic optical property to generate a control signal and directly under the control of said control signal transmitting via said cable means from said proximal end to said distal end, periodically occurring laser pulses until said characteristic optical property is no longer sensed.
Claim 2
Independent Claim 127 words
The method of destroying atheromatous plaque within an artery of a patient comprising the steps of initially administering to the patient a non-toxic atheroma-enhancing reagent which causes the plaque to have a characteristic optical property when illuminated with a given radiation, introducing a catheter system including fiberoptic cable means into the artery such that the distal end thereof is operatively opposite the plaque site, introducing into the proximal end of said fiberoptic cable means said given radiation, photoelectrically sensing at said proximal end said characteristic optical property to generate a control signal and directly under the control of said control signal transmitting via said cable means from said proximal end to said distal end, periodically occurring laser pulses until said characteristic optical property is no longer sensed.
Claim 3
Dependent Claim 26 words
The method of claim 1 wherein said reagent causes the plaque to fluoresce with a particular wavelength when irradiated with a given wavelength of electromagnetic radiation.
Claim 4
Dependent Claim 17 words
The method of claim 2 wherein said reagent is tetracycline and said electromagnetic radiation is ultraviolet light.
Claim 5
Dependent Claim 13 words
The method of claim 2 wherein said reagent is the dye nile red.
Claim 6
Independent Claim 170 words
The method of irradiating a treatment area within an intact body channel inaccessible to direct viewing by introducing a catheter system including a fiberoptic cable means functioning as a bidirectional energy-transfer conduit into the intact body channel until the distal end of said cable means is operatively opposite the treatment area while the proximal end is external to said intact body channel, at the proximal end of said fiberoptic cable means transferring first radiation via said cable means to said treatment area, at the proximal end photoelectrically sensing for a particular optical property of the treatment area in response to said first radiation to generate a control signal, providing a source of laser energy at the proximal end of said cable means whereby laser energy passes via said cable means to the treatment area, and utilizing said control signal to control the generation of pulses of laser energy so that pulses of laser energy are terminated when said particular optical property of the treatment area is no longer photoelectrically sensed.
Claim 7
Independent Claim 170 words
The method of irradiating a treatment area within an intact body channel inaccessible to direct viewing by introducing a catheter system including a fiberoptic cable means functioning as a bidirectional energy-transfer conduit into the intact body channel until the distal end of said cable means is operatively opposite the treatment area while the proximal end is external to said intact body channel, at the proximal end of said fiberoptic cable means transferring first radiation via said cable means to said treatment area, at the proximal end photoelectrically sensing for a particular optical property of the treatment area in response to said first radiation to generate a control signal, providing a source of laser energy at the proximal end of said cable means whereby laser energy passes via said cable means to the treatment area, and utilizing said control signal to control the generation of pulses of laser energy so that pulses of laser energy are terminated when said particular optical property of the treatment area is no longer photoelectrically sensed.
Claim 8
Dependent Claim 40 words
The method of claim 5 further comprising, before transmitting the laser pulses, the step of introducing into the treatment area a reagent which will cause the treatment area to fluoresce with a given wavelength when subject to said first radiation.
Claim 9
Dependent Claim 17 words
The method of claim 5 further comprising preventing photoelectric sensing during the occurrence of a laser pulse.
Claim 10
Independent Claim 122 words
The method of destroying atheromatous plaque within an artery of a patient, said plaque having a characteristic optical property when illuminated with a given radiation comprising the steps of introducing a catheter system including fiberoptic cable means into the artery such that the distal end thereof is operatively opposite the plaque site and the proximal external to the patient, introducing into the proximal end of said fiberoptic cable means said given radiation, photoelectrically sensing at said proximal end said characteristic optical property to generate a control signal and directly under the control of said control signal transmitting via said cable means from said proximal end to said distal end, periodically occurring laser pulses until said characteristic optical property is no longer sensed.
Claim 11
Independent Claim 122 words
The method of destroying atheromatous plaque within an artery of a patient, said plaque having a characteristic optical property when illuminated with a given radiation comprising the steps of introducing a catheter system including fiberoptic cable means into the artery such that the distal end thereof is operatively opposite the plaque site and the proximal external to the patient, introducing into the proximal end of said fiberoptic cable means said given radiation, photoelectrically sensing at said proximal end said characteristic optical property to generate a control signal and directly under the control of said control signal transmitting via said cable means from said proximal end to said distal end, periodically occurring laser pulses until said characteristic optical property is no longer sensed.

References Cited (Backward Citations)

US3975748A Cited
DE2517129B1 Cited
US4207874A Cited
US4266549A Cited
USRE31815E Cited
US4336809A Cited
US4316467A Cited
US4438765A Cited
US4418688A Cited
US4454882A Cited
US4551829A Cited
US4550240A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-07-27 1991-01-26 1991-07-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-07-27 1995-01-26 1995-07-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-07-27 1999-01-26 1999-07-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag